Skip to main content

Table 1 Summary of demographic and socioeconomic characteristics of participants

From: Navigating the implementation gap for Trastuzumab's journey from health insurance to patient access: a preliminary study in a hospital in China

 

Total, % (n = 766)

CerbB2 2 + , % (n = 495)

CerbB2 3 + , % (n = 271)

P-value

Age at diagnosis

< 35

2.61

2.83

2.21

0.086

35–44

12.14

11.72

12.92

 

45–54

39.95

38.18

43.17

 

55–64

30.16

29.49

31.37

 

 ≥ 65

15.14

17.78

10.33

 

Mean (range, SD)

54.11 (21–92, 10.36)

54.78 (26–92, 10.90)

52.89 (21–77, 9.18)

 

Educational Level

Junior high school or below

68.02

67.07

69.74

0.294

High school or technical school

6.53

7.47

4.8

 

Bachelor's or associate degree

6.27

6.67

5.54

 

Missing

18.79

19.92

18.79

 

Marital Status

Married

87.86

86.06

91.14

0.777

Divorced

0.52

0.4

0.74

 

Widowed

0.91

1.01

0.74

 

Single

0.65

0.81

0.37

 

Missing

10.06

11.72

7.01

 

Medical insurance1*

UEBMI

46.34

38.99

59.78

0.066

URRBMI

7.57

8.28

6.27

 

Self-pay

4.7

4.04

5.9

 

Missing

41.39

48.69

28.05

 

Number of Childbirths

0

1.83

2.02

1.48

0.181

1

56.14

52.53

62.73

 

2

28.2

28.48

27.68

 

 >  = 3

3.52

16.97

1.48

 

Missing

10.31

0

6.63

 

Time of discharge from hospital

2013

4.96

6.87

1.48

 < 0.001

2014

7.05

5.25

10.33

 

2015

7.44

7.07

8.12

 

2016

5.35

4.24

7.38

 

2017

6.53

3.64

11.81

 

2018

11.88

7.68

19.56

 

2019

24.67

30.3

14.39

 

2020

17.36

18.18

15.87

 

2021

9.79

11.52

6.64

 

2022

4.96

5.25

4.43

 

TNM Stage2

0

1.04

0.81

1.48

0.684

I

42.69

44.24

39.85

 

II

38.90

38.18

40.22

 

III

13.84

14.75

12.18

 

IV

0.26

0.2

0.37

 

Missing

3.27

1.82

5.9

 
  1. 1. UEBMI Urban Employee Basic Medical Insurance; URRBMI Urban and Rural Residents Basic Medical Insurance
  2. 2. The TNM system is utilized to characterize cancer's extent and spread in a patient's body. It encompasses T for tumor size and local spread, N for lymph node involvement, and M for metastasis. Developed and maintained by the American Joint Committee on Cancer (AJCC) and the International Union Against Cancer (UICC), this system is widely employed across various cancer types